Patents by Inventor Ramsharan Singh

Ramsharan Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising disodium levofolinate
    Patent number: 11541012
    Abstract: Provided herein are compositions comprising disodium levofolinate. Also provided are processes for preparing compositions comprising disodium levofolinate. Also provided are compositions comprising disodium levofolinate prepared by the processes provided herein. Also provided are methods of treating folic acid deficiency in a subject in need thereof, comprising administering a composition provided herein to the subject. Also provided are methods of treating cancer in a subject in need thereof, comprising administering 5-fluorouracil and a composition provided herein to the subject. Also provided are methods of reducing the immediate toxic effects of methotrexate overdose in a subject in need thereof, comprising administering a composition provided herein to the subject. Also provided are methods of treating cancer in a subject in need thereof, comprising administering high-dose methotrexate and a composition provided herein to the subject.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: January 3, 2023
    Assignee: Acrotech Biopharma, LLC
    Inventors: Ramsharan Singh, Bahman Shimiaei
  • Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
    Publication number: 20220347210
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: July 11, 2022
    Publication date: November 3, 2022
    Applicant: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
    Patent number: 11406663
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: August 9, 2022
    Assignee: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
    Publication number: 20200093859
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: June 6, 2019
    Publication date: March 26, 2020
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
    Patent number: 10350240
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: July 16, 2019
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
    Patent number: 8961917
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: February 24, 2015
    Assignee: Spectrum Pharmaceuticals, Inc.
    Inventors: Ashok Yeshwant Gore, Edward A. Schauer, Matthew Stewart, Ramsharan Singh
  • LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE
    Publication number: 20140161885
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 12, 2014
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lyophilized formulations of Salinosporamide A
    Patent number: 7824698
    Abstract: Lyophilized formulations comprising Salinosporamide A or analogs thereof are provided. In some aspects, lyophilized formulations comprising Salinosporamide A or analogs thereof and bulking agents are provided. Also provided are methods of lyophilizing Salinosporamide A or analogs thereof. In some aspects, a solvent or co-solvent system is utilized. Also provided are methods of administering Salinosporamide A or analogs thereof to patients.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: November 2, 2010
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Barbara Potts, Ramsharan Singh, Jan-Jon Chu, Bao Viet Mai, Natasha Reddinger, Cheryl (Billstrom) Sifferlen
  • LYOPHILIZED FORMULATIONS OF SALINOSPORAMIDE A
    Publication number: 20080188544
    Abstract: Lyophilized formulations comprising Salinosporamide A or analogs thereof are provided. In some aspects, lyophilized formulations comprising Salinosporamide A or analogs thereof and bulking agents are provided. Also provided are methods of lyophilizing Salinosporamide A or analogs thereof. In some aspects, a solvent or co-solvent system is utilized. Also provided are methods of administering Salinosporamide A or analogs thereof to patients.
    Type: Application
    Filed: February 4, 2008
    Publication date: August 7, 2008
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Barbara Potts, Ramsharan Singh, Jan-Jon Chu, Bao Viet Mai, Natasha Reddinger, Cheryl Sifferlen